HIV/AIDS
Investigators from University of California, U.S., publish new HIV/AIDS data
Published in AIDS Weekly, August 6th, 2007
Study 1: A new study, "Protease inhibitors and cardiovascular disease: analysis of the Los Angeles County adult spectrum of disease cohort," is now available. "Since protease inhibitors (PIs) were first introduced in 1995, research has shown that use of PIs greatly improves rates of survival, while slowing HIV disease progression. However, there are concerns that use of PIs may be associated with an increased risk of cardiovascular disease (CVD)," researchers in the United States report.
"To examine the relationship between PI use and CVD among HIV-infected patients,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2007-08-06)
More Articles from AIDS Weekly
- Flu Vaccines
Studies affirm need for influenza and measles vaccinations in HIV-infected patients - HIV/AIDS
America's 'anti-prostitution pledge' is hindering global HIV control efforts - HIV/AIDS
Carnegie Mellon scientists find key HIV protein makes cell membranes bend more easily - HIV/AIDS
Male circumcision for HIV prevention and more - HIV/AIDS
U of M researchers discover new method to combat HIV - HIV/AIDS
144-Week Data from Gilead's Study 934 Comparing Truvada to Combivir Both in Combination with Sustiva Presented At International AIDS Society Meeting in Sydney - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
